HuGE Literature Finder
Records
1
-
11
| Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer. Genes 2018 Dec 9 (12): . Furuya Tatiane K, Jacob Carlos E, Tomitão Michele T P, Camacho Lizeth C C, Ramos Marcus F K P, Eluf-Neto José, Alves Venâncio A F, Zilberstein Bruno, Cecconello Ivan, Ribeiro Ulysses, Chammas Rog |
| Association of 758 G/A polymorphism of 3'untranslated region of prohibitin with risk of gastric cancer. Journal of clinical laboratory analysis 2018 Jan 32 (1): . Xiang Fenfen, Ni Zhenhua, Zhan Yueping, Xu Jian, Wu Rong, Kang Xiangdo |
| Genetic determinants of sporadic breast cancer in Sri Lankan women. BMC cancer 2018 02 18 (1): 180. Sirisena Nirmala Dushyanthi, Adeyemo Adebowale, Kuruppu Anchala I, Neththikumara Nilaksha, Samaranayake Nilakshi, Dissanayake Vajira H |
| Relative normalized luciferase activity for the recombinant vector constructs carrying the ancestral and variant alleles for XRCC2:rs3218550 and PHB:rs6917. BMC research notes 2018 9 11 (1): 643. Sirisena Nirmala Dushyanthi, Samaranayake Nilakshi, Dissanayake Vajira H |
| Prohibitin expression deregulation in gastric cancer is associated with the 3' untranslated region 1630 C>T polymorphism and copy number variation. PloS one 2014 9 (5): e98583. Leal Mariana Ferreira, Cirilo Priscila Daniele Ramos, Mazzotti Tatiane Katsue Furuya, Calcagno Danielle Queiroz, Wisnieski Fernanda, Demachki Samia, Martinez Margarita Cortes, Assumpção Paulo Pimentel, Chammas Roger, Burbano Rommel Rodríguez, Smith Marília Cardo |
| Mutational analysis of prohibitin--a highly conserved gene in Indian female breast cancer cases. Asian Pacific journal of cancer prevention : APJCP 2012 13 (10): 10. Najm MZ, Akhtar MS, Ahmad I, Mallick MN, Kausar MA, Chattopadhyay S, Ahad A, Zaidi S, Husain SA, Siddiqui WA |
| Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. British journal of cancer 2012 Jun 106 (12): 2016-24. Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott R J, McGuffog L, Healy S, Sinilnikova O M, Rennert G, Lejbkowicz F, Flugelman A, Andrulis I L, Glendon G, Ozcelik H, , Thomassen M, Paligo M, Aretini P, , Kantala J, Aroer B, von Wachenfeldt A, Liljegren A, Loman N, Herbst K, Kristoffersson U, Rosenquist R, Karlsson P, Stenmark-Askmalm M, Melin B, Nathanson K L, Domchek S M, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Serrano P, Osorio A, Cajal T R, Tsitlaidou M, Benítez J, Gilbert M, , Rookus M, Aalfs C M, Kluijt I, Boessenkool-Pape J L, Meijers-Heijboer H E J, Oosterwijk J C, van Asperen C J, Blok M J, Nelen M R, van den Ouweland A M W, Seynaeve C, van der Luijt R B, Devilee P, , Easton D F, Peock S, Frost D, Platte R, Ellis S D, Fineberg E, Evans D G, Lalloo F, Eeles R, Jacobs C, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Godwin A, Bove B, , Stoppa-Lyonnet D, Caux-Moncoutier V, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Boutry-Kryza N, Pujol P, Coupier I, Peyrat J-P, Vennin P, Muller D, Fricker J-P, Venat-Bouvet L, Johannsson O Th, Isaacs C, Schmutzler R, Wappenschmidt B, Meindl A, Arnold N, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Preisler-Adams S, Simard J, Soucy P, Durocher F, Chenevix-Trench G, Beesley J, Chen X, , Rebbeck T, Couch F, Wang X, Lindor N, Fredericksen Z, Pankratz V S, Peterlongo P, Bonanni B, Fortuzzi S, Peissel B, Szabo C, Mai P L, Loud J T, Lubinski J, |
| A SNP in steroid receptor coactivator-1 disrupts a GSK3ß phosphorylation site and is associated with altered tamoxifen response in bone. Molecular endocrinology (Baltimore, Md.) 2012 Feb 26 (2): 220-7. Hartmaier R J, Richter A S, Gillihan R M, Sallit J Z, McGuire S E, Wang J, Lee A V, Osborne C K, O'Malley B W, Brown P H, Xu J, Skaar T C, Philips S, Rae J M, Azzouz F, Li L, Hayden J, Henry N L, Nguyen A T, Stearns V, Hayes D F, Flockhart D A, Oesterreich |
| Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? European journal of cancer (Oxford, England : 1990) 2009 Mar 45 (5): 837-42. Jakubowska Anna, Jaworska Katarzyna, Cybulski Cezary, Janicka Anna, Szyma?ska-Pasternak Jolanta, Lener Marcin, Narod Steven A, Lubi?ski Jan, |
| Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. BMC cancer 2008 8 (1): 90. Jakubowska Anna, Gronwald Jacek, Menkiszak Janusz, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, Benner Axel, Lubi?ski Jan, Scott Rodney J, Hamann U |
| The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast cancer research and treatment 2007 Jul 104 (1): 67-74. Jakubowska Anna, Gronwald Jacek, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, Benner Axel, Lubi?ski Jan, Scott Rodney J, Hamann U |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: